latest update:
[TrialBase DB]

Coverage · what the dataset can prove

Coverage is the public checklist for evaluating a pack before purchase: exported records, active sources, field groups, workflow fit, and the caveats that limit interpretation.

Record coverage

The public counts below come from export-ready records and the source registry. They update with every snapshot cut instead of being hand-maintained in website copy.

Included trials
702,863

Canonical trial rows in the current dated release; this is not an upstream registry total.

ClinicalTrials.gov contributions
609,551

Distinct exported canonical trials with an active ClinicalTrials.gov source contribution in the measured release.

EU CTIS contributions
12,749

Distinct exported canonical trials with an active EU CTIS source contribution in the measured release.

EudraCT contributions
44,415

Distinct exported canonical trials with an active EU Clinical Trials Register source contribution in the measured release.

ISRCTN contributions
28,931

Distinct exported canonical trials with an active ISRCTN source contribution in the measured release.

Licensed DRKS contributions
7,578

Distinct exported canonical trials with an active DRKS contribution admitted by the registered-from-2025 or last-updated-in-2025 licence gate.

Freshness policy
Weekly refresh

Maximum age 8 days. Oldest measured source refresh: 2026-11-02.

Weekly publication requires complete evidence no more than eight days old for four full registry crawls, the licensed DRKS slice, Health Canada CTD, and exact-edge PubMed.

/trials records
702,863
active sources
7
provenance rows
13,401,718
These are export-ready counts, not a claim that every field is populated for every record. Field-level coverage is documented in the data dictionary and source notes.

Field coverage

Schema groups come from the exported field model and curated field highlights. They are the default coverage map for filtering, joining, and reviewer audit work.

groupfieldsexamples
Identity and registry5id, primary_registry, registry_id, source_record_url
Titles and summaries3brief_title, official_title, brief_summary
Status and design6overall_status, phase, study_type, primary_purpose
Sponsor2sponsor_name, sponsor_class
Enrollment and dates4start_date, completion_date, enrollment_count, primary_completion_date
Provenance1_provenance
Conditions and interventions5lead_condition, conditions, interventions, intervention_types
Outcomes and publications3outcomes, outputs, publications
Regulatory1regulatory_records
documented fields
30
domain fields
29
provenance-aware fields
7

Source coverage

Source descriptions make coverage visible before a buyer logs into the portal or downloads the full snapshot.

ClinicalTrials.govcommercial-use cleared

Registry-reported study records from the U.S. National Library of Medicine ClinicalTrials.gov service.

DRKScommercial-use cleared

Current DRKS records registered from 2025 onward or, for older registrations, last updated during 2025; the connector enforces that row-level licence gate and retains the public DRKS record link.

EU CTIScommercial-use cleared

Public clinical-trial records from the European Union Clinical Trials Information System.

EU CTR / EudraCTcommercial-use cleared

Public EudraCT study records from the European Union Clinical Trials Register.

Workflow coverage

These use cases are the workflows this dataset is positioned to support. The same workflow set appears on the homepage, sample page, and agent-facing docs.

Search across registries

Find studies by condition, intervention, sponsor, or registry identifier.

Build research datasets

Download study records with release dates, registry identifiers, and source links.

Link registry IDs

Review records linked across ClinicalTrials.gov, CTIS, EudraCT, ISRCTN, and the included DRKS subset.

Check registry coverage

Review included registries, available fields, and source refresh dates.

Limits

Coverage claims should stay bounded by the manifest caveats and source licence terms.

  • TrialBase DB is reference data, not medical advice, trial recruitment advice or regulatory advice.
  • Buyers remain responsible for validating suitability for regulated clinical, commercial or publication workflows.
  • Array fields preserve registry-reported terms after trimming and exact-repeat deduplication; completeness and selected provenance are release-level measurements, not schema guarantees.

Related evaluation guides

Connect this diligence evidence to the relevant integration decision.